Jason W Bae, MD
Internal Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bae’s office at (415) 600-1020 to ask if they take your plan before you enroll.
California Medical Board record
Licence A147848 · Current
Licensed to practise in California · since 2017 · expires 2027-01-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$76,163
Medicare paid this office $76,163 for 518 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 234 | $28,391 | $114 |
| New patient visit (45+ min) | 84 | $11,842 | $141 |
| Long return visit (40+ min) | 66 | $11,513 | $167 |
| Short return visit (20+ min) | 83 | $6,155 | $73 |
| New patient visit (30+ min) | 46 | $3,330 | $72 |
See all 12 services
| Return visit (30+ min) | 234 | $28,391 | $114 |
| New patient visit (45+ min) | 84 | $11,842 | $141 |
| Long return visit (40+ min) | 66 | $11,513 | $167 |
| Short return visit (20+ min) | 83 | $6,155 | $73 |
| New patient visit (30+ min) | 46 | $3,330 | $72 |
| New patient visit (60+ min) | 16 | $2,961 | $185 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 20 | $2,796 | $140 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 20 | $1,484 | $67 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 15 | $710 | $47 |
| Injection of drug or substance under skin or into muscle | 18 | $243 | $14 |
| Automated urinalysis test | 43 | $101 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 31 | $49 | None |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
518 Original Medicare patients in 2024. Average age 78 · Women 58% · Also on Medicaid 8% · Health risk score 1.01. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 64% · Atrial fibrillation 25% · Coronary heart disease 24% · Diabetes 19% · Chronic kidney disease 19% · Cancer 19% · Depression 16% · Heart failure 15% · COPD 7% · Stroke 7% · Dementia 6%.
The office billed $279,473, Medicare allowed $103,888 and paid $76,163; for 1,833 services of 59 kinds; $1,638 of it was for drugs given in the office and $74,525 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 518 | 1,833 | 78 | 1.01 | $279,473 | $76,163 |
| 2023 | 520 | 2,932 | 78 | 0.98 | $249,659 | $71,107 |
| 2022 | 495 | 3,791 | 78 | 0.95 | $254,737 | $73,886 |
| 2021 | 270 | 1,425 | 78 | 1.04 | $123,090 | $38,921 |
| 2020 | 163 | 354 | 77 | 1.05 | $59,069 | $15,068 |
| 2019 | 63 | 107 | 75 | 1.31 | $21,819 | $6,218 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 225 | $27,091 | $113 |
| Long return visit (40+ min) | 50 | $8,718 | $171 |
| Short return visit (20+ min) | 112 | $8,647 | $76 |
| New patient visit (45+ min) | 62 | $8,228 | $133 |
| New patient visit (30+ min) | 78 | $6,822 | $87 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 19 | $2,656 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 28 | $1,408 | $50 |
| Wound closure utilizing tissue adhesive(s) only | 11 | $1,365 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 14 | $1,125 | $70 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 20 | $324 | $16 |
| Injection of drug or substance under skin or into muscle | 15 | $201 | $13 |
| Automated urinalysis test | 62 | $139 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 18 | $35 | None |
2022: 11 services
| Return visit (30+ min) | 191 | $22,885 | $114 |
| Long return visit (40+ min) | 56 | $9,553 | $165 |
| Short return visit (20+ min) | 125 | $9,450 | $75 |
| New patient visit (45+ min) | 57 | $8,454 | $148 |
| New patient visit (30+ min) | 56 | $5,168 | $92 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 50 | $2,635 | $51 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 16 | $1,132 | $67 |
| Injection of drug or substance under skin or into muscle | 34 | $622 | $14 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $507 | $30 |
| Automated urinalysis test | 44 | $104 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 21 | $35 | None |
2021: 10 services
| Long return visit (40+ min) | 60 | $10,430 | $171 |
| Return visit (30+ min) | 82 | $10,316 | $120 |
| Short return visit (20+ min) | 65 | $5,358 | $82 |
| New patient visit (45+ min) | 15 | $2,320 | $155 |
| New patient visit (30+ min) | 22 | $2,256 | $103 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $872 | $51 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $623 | $31 |
| Injection of drug or substance under skin or into muscle | 17 | $258 | $14 |
| Automated urinalysis test | 27 | $65 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 15 | $29 | None |
2020: 3 services
| Return visit (30+ min) | 72 | $6,296 | $86 |
| Short return visit (20+ min) | 53 | $3,551 | $67 |
| New patient visit (30+ min) | 14 | $1,004 | $72 |
2019: 2 services
| Return visit (30+ min) | 22 | $2,117 | $96 |
| Short return visit (20+ min) | 29 | $2,020 | $70 |
Drugs they prescribed that Part D paid
$10,622
Pharmacies billed $10,622 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (12 of 449) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
400 generic and fewer than 11 brand-name prescriptions · $10,622 in drug cost · 132 antibiotic prescriptions to 112 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 43 | $315 | $7 |
| Tamsulosin | 40 | $200 | $5 |
| Atorvastatin | 36 | $194 | $5 |
| Nitrofurantoin Mono-Macro | 16 | $147 | $9 |
| Amoxicillin-Clavulanate Potass | 25 | $141 | $6 |
See all 12 drugs
| Gabapentin | 43 | $315 | $7 |
| Tamsulosin | 40 | $200 | $5 |
| Atorvastatin | 36 | $194 | $5 |
| Nitrofurantoin Mono-Macro | 16 | $147 | $9 |
| Amoxicillin-Clavulanate Potass | 25 | $141 | $6 |
| Cephalexin | 27 | $141 | $5 |
| Mupirocin | 21 | $116 | $6 |
| Doxycycline Hyclate | 14 | $109 | $8 |
| Finasteride | 11 | $102 | $9 |
| Azithromycin | 28 | $96 | $3 |
| Prednisone | 20 | $52 | $3 |
| Paxlovid | 23 | $0 | $0 |
Year by year
| 2024 | 449 | 241 | 3% (12) | None | $10,622 |
| 2023 | 448 | 235 | None | 8% | $10,872 |
| 2022 | 396 | 195 | 3% (13) | 6% | $7,234 |
| 2021 | 263 | 90 | None | 5% | $5,735 |
| 2020 | 286 | 60 | None | 8% | $7,347 |
| 2019 | 625 | 152 | None | None | $41,897 |
| 2018 | 1,426 | 256 | 3% (41) | None | $118,285 |
| 2017 | 250 | 56 | None | None | $12,599 |
| 2016 | 263 | 43 | 5% (14) | None | $22,720 |
| 2015 | 230 | 29 | None | None | $11,016 |
| 2014 | 55 | 16 | None | None | $5,451 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Tamsulosin | 39 | $727 | $19 |
| Gabapentin | 49 | $349 | $7 |
| Atorvastatin | 36 | $295 | $8 |
| Mupirocin | 29 | $283 | $10 |
| Paxlovid (Eua) | 23 | $243 | $11 |
| Cephalexin | 34 | $218 | $6 |
| Cefdinir | 12 | $213 | $18 |
| Finasteride | 12 | $142 | $12 |
| Nitrofurantoin Mono-Macro | 12 | $123 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $107 | $7 |
| Azithromycin | 15 | $63 | $4 |
2022: 9 drugs
| Tamsulosin | 46 | $933 | $20 |
| Atorvastatin | 41 | $322 | $8 |
| Paxlovid (Eua) | 22 | $227 | $10 |
| Gabapentin | 43 | $226 | $5 |
| Nitrofurantoin Mono-Macro | 16 | $215 | $13 |
| Mupirocin | 25 | $193 | $8 |
| Cephalexin | 23 | $168 | $7 |
| Finasteride | 11 | $146 | $13 |
| Prednisone | 21 | $59 | $3 |
2021: 5 drugs
| Tamsulosin | 45 | $816 | $18 |
| Atorvastatin | 44 | $319 | $7 |
| Gabapentin | 48 | $245 | $5 |
| Finasteride | 11 | $141 | $13 |
| Cephalexin | 19 | $141 | $7 |
2020: 5 drugs
| Tamsulosin | 57 | $820 | $14 |
| Atorvastatin | 59 | $371 | $6 |
| Gabapentin | 61 | $371 | $6 |
| Finasteride | 11 | $146 | $13 |
| Cephalexin | 11 | $49 | $4 |
2019: 21 drugs
| Lantus Solostar | 38 | $6,767 | $178 |
| Brilinta | 26 | $3,692 | $142 |
| Humalog Kwikpen U-100 | 21 | $3,241 | $154 |
| Gabapentin | 26 | $1,521 | $58 |
| Atorvastatin | 22 | $965 | $44 |
| Tamsulosin | 13 | $820 | $63 |
| Amlodipine Besylate | 27 | $552 | $20 |
| Metoprolol | 20 | $515 | $26 |
| Finasteride | 13 | $472 | $36 |
| Levothyroxine | 11 | $283 | $26 |
| Pravastatin | 13 | $269 | $21 |
| Montelukast | 16 | $234 | $15 |
| Allopurinol | 11 | $223 | $20 |
| Azithromycin | 11 | $199 | $18 |
| Ciprofloxacin | 11 | $163 | $15 |
| Pantoprazole | 14 | $157 | $11 |
| Furosemide | 21 | $109 | $5 |
| Lisinopril | 14 | $66 | $5 |
| Levofloxacin | 11 | $40 | $4 |
| Cephalexin | 11 | $34 | $3 |
| Prednisone | 11 | $20 | $2 |
2018: 40 drugs
| Humulin 70/30 Kwikpen | 23 | $18,251 | $794 |
| Eliquis | 31 | $11,432 | $369 |
| Brilinta | 35 | $5,263 | $150 |
| Humalog Kwikpen U-100 | 31 | $4,952 | $160 |
| Spiriva | 20 | $3,698 | $185 |
| Lantus Solostar | 24 | $2,394 | $100 |
| Gabapentin | 45 | $2,008 | $45 |
| Atorvastatin | 62 | $1,651 | $27 |
| Metoprolol | 29 | $1,450 | $50 |
| Levothyroxine | 39 | $924 | $24 |
| Tamsulosin | 18 | $876 | $49 |
| Omeprazole | 16 | $752 | $47 |
| Sertraline | 32 | $631 | $20 |
| Amlodipine Besylate | 27 | $579 | $21 |
| Glimepiride | 13 | $476 | $37 |
| Ondansetron | 11 | $474 | $43 |
| Mirtazapine | 12 | $413 | $34 |
| Warfarin | 18 | $399 | $22 |
| Furosemide | 43 | $385 | $9 |
| Losartan | 27 | $382 | $14 |
| Carvedilol | 31 | $363 | $12 |
| Metformin | 25 | $353 | $14 |
| Pravastatin | 21 | $340 | $16 |
| Pantoprazole | 24 | $340 | $14 |
| Lisinopril | 29 | $332 | $11 |
| Ciprofloxacin | 19 | $316 | $17 |
| Isosorbide Mononitrate Er | 14 | $307 | $22 |
| Clopidogrel | 12 | $305 | $25 |
| Risperidone | 14 | $283 | $20 |
| Hydrocodone-Acetaminophen | 15 | $282 | $19 |
| Trazodone | 19 | $281 | $15 |
| Clonazepam | 12 | $274 | $23 |
| Levofloxacin | 12 | $247 | $21 |
| Benazepril | 26 | $239 | $9 |
| Metoprolol | 22 | $229 | $10 |
| Simvastatin | 16 | $229 | $14 |
| Citalopram Hbr | 19 | $203 | $11 |
| Cefdinir | 11 | $193 | $18 |
| Famotidine | 11 | $102 | $9 |
| Prednisone | 25 | $96 | $4 |
2017: 5 drugs
| Atorvastatin | 19 | $392 | $21 |
| Metoprolol | 17 | $339 | $20 |
| Gabapentin | 15 | $243 | $16 |
| Amlodipine Besylate | 11 | $185 | $17 |
| Lisinopril | 14 | $161 | $12 |
2016: 4 drugs
| Metoprolol | 29 | $1,211 | $42 |
| Atorvastatin | 16 | $408 | $25 |
| Gabapentin | 20 | $378 | $19 |
| Lisinopril | 13 | $62 | $5 |
2015: 4 drugs
| Metoprolol | 17 | $673 | $40 |
| Gabapentin | 19 | $345 | $18 |
| Omeprazole | 14 | $63 | $5 |
| Clonazepam | 11 | $43 | $4 |
Professional record
- NPI
- 1497168074
- Licence
- CA A147848, MA L-259358California A147848: Current · expires 2027-01-31
- Trained
- Yale University School of Medicine, 2014
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-06-11
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301 · 255 N White Rd Ste 200, San Jose, CA, 95127